Karyopharm Therapeutics
KPTI
KPTI
87 hedge funds and large institutions have $41.2M invested in Karyopharm Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $49.2M → $41.2M (-$8.02M)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Holders
87
Holding in Top 10
–
Calls
$196K
Puts
$47K
Top Buyers
| 1 | +$2.29M | |
| 2 | +$1.35M | |
| 3 | +$368K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$245K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$217K |
Top Sellers
| 1 | -$2.34M | |
| 2 | -$934K | |
| 3 | -$750K | |
| 4 |
D.E. Shaw & Co
New York
|
-$553K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$452K |